FWP

Forward Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.47
-0.15
-2.27%
Closed 16:00 10/28 EDT
OPEN
6.70
PREV CLOSE
6.62
HIGH
6.76
LOW
6.34
VOLUME
39.88K
TURNOVER
--
52 WEEK HIGH
12.72
52 WEEK LOW
4.610
MARKET CAP
44.21M
P/E (TTM)
-3.7409
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
A Trio of Stock Picks for the Short-Term Investor
These companies are trading below the liquidation value Continue reading...
GuruFocus.com · 07/14 20:01
Momentum's Still In Bloom In May As Summer Trading Approaches
Halfway through May and my trading account is rounding the corner on its most profitable span after. After last month’s all-green April and the first couple weeks of May, I’ve managed to add more than $160,000 in gross profits to my account.
Benzinga · 05/15 18:51
60 Biggest Movers From Yesterday
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares surged 71.1% to close at $15.21 on Thursday after the company announced it has received FDA emergency use authorization for its coronavirus diagnostic assay kit.
Benzinga · 05/15 08:53
42 Stocks Moving In Thursday's Mid-Day Session
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) jumped 53.4% to $13.64 after the company announced it has received FDA emergency use authorization for its coronavirus diagnostic assay kit.
Benzinga · 05/14 18:57
Forward Pharma up 10% on extended timeline for patent appeal
Thinly traded nano cap Forward Pharma A/S (FWP +10.4%) is up on a whopping 166x surge in volume on a temporary reprieve on the revocation of its European p
seekingalpha · 05/13 21:22
50 Stocks Moving In Wednesday's Mid-Day Session
Gainers SIFCO Industries, Inc. (NYSE: SIF) shares jumped 117% to $4.7799 following Q2 results. Sifco Industries posted Q2 earnings of $0.57 per share, versus a year-ago loss of $0.43 per share.
Benzinga · 05/13 16:41
50 Stocks Moving In Wednesday's Mid-Day Session
Gainers SIFCO Industries, Inc. (NYSE: SIF) shares jumped 117% to $4.7799 following Q2 results. Sifco Industries posted Q2 earnings of $0.57 per share, versus a year-ago loss of $0.43 per share.
Benzinga · 05/13 16:41
Stocks That Hit 52-Week Highs On Wednesday
This morning 35 companies set new 52-week highs.
Benzinga · 05/13 14:35
More
Forecast
EPSBVPSCFPS
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of FWP. Analyze the recent business situations of Forward Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average FWP stock price target is 37.00 with a high estimate of 37.00 and a low estimate of 37.00.
EPS
Institutional Holdings
Institutions: 19
Institutional Holdings: 860.98K
% Owned: 12.68%
Shares Outstanding: 6.79M
TypeInstitutionsShares
Increased
2
64.11K
New
5
-281.37K
Decreased
2
279.37K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.66%
Pharmaceuticals & Medical Research
-1.08%
Key Executives
Chief Executive Officer
Claus Svendsen
Chief Financial Officer
Joel Sendek
Controller/Vice President
Thomas Carbone
Director/Chairman
Florian Schonharting
Director
Torsten Goesch
Director
Jan van de Winkel
Non-Executive Director
Duncan Moore
Non-Executive Director
Karen Smith
Independent Director
J. Kevin Buchi
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 23.123008
09/12/2017
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About FWP
Forward Pharma A/S is a Denmark-based bio-pharmaceutical company. It is developing a proprietary formulation of dimethyl fumarate (DMF), for the treatment of multiple sclerosis (MS) and other inflammatory and neurological indications. DMF is an immunomodulator that can be used as a therapeutic to improve the health of patients with MS and immune disorders .The Company is headquartered in Copenhagen, Denmark.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Forward Pharma A/S stock information, including NASDAQ:FWP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FWP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FWP stock methods without spending real money on the virtual paper trading platform.